온코네틱스(ONCO)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.66 (-0.54%), 시가총액 $0.00B, 52주 최저~최고 $0.07 ~ $4.92.
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnat
온코네틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
온코네틱스의 현재 주가는 $0.66 (-0.54%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
온코네틱스의 시가총액은 약 $0.00B입니다.
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-Europ